Message Font: Serif | Sans-Serif
 
No. of Recommendations: 0
Urche,

Thank you for your expertise. That was exactly the kind of information I was seeking. Niche drugs make for great acquisitions if there are other possible uses that can expand sales. It doesn't sound like there would be other possibilities for these particular drugs. I doubt KG's sales force can find any additional markets if the uses for theses drugs turn out to be that limited. To be honest, I'm a little disappointed in the purchase after reading your post and doing a little more research. I've come to respect the management for their shrewd purchases but the more I look for sales growth for all three of these drugs (particularly the anti-biotic) the more I see this deal as a marginally profitable and not worth the risk.

Derek - still long on KG but not buying more for the moment
Print the post  

Announcements

What was Your Dumbest Investment?
Share it with us -- and learn from others' stories of flubs.
When Life Gives You Lemons
We all have had hardships and made poor decisions. The important thing is how we respond and grow. Read the story of a Fool who started from nothing, and looks to gain everything.
Contact Us
Contact Customer Service and other Fool departments here.
Work for Fools?
Winner of the Washingtonian great places to work, and Glassdoor #1 Company to Work For 2015! Have access to all of TMF's online and email products for FREE, and be paid for your contributions to TMF! Click the link and start your Fool career.